CompaniesDA VOLTERRA

DA VOLTERRA

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

4

As Collaborator

2

Total Enrollment

4,973

By Phase

NA: 1PHASE1: 2

By Status

COMPLETED: 6
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Today
NCT01591538
Hover over trial bars to see details

Recent Trials

NCT03710694Lead Sponsor
Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI)
NACompleted
260 participants
Started: Oct 31, 2018 · Completed: Aug 9, 2019
NCT03503474Collaborator
COMBACTE-CDI Understanding the Burden of C. Difficile Infection
N/ACompleted
3,240 participants
Started: Jun 11, 2018 · Completed: Sep 30, 2019
NCT02896244Collaborator
AssessmeNT of the Incidence of Clostridium Difficile Infections in Hospitalized Patients on Antibiotic TrEatment
N/ACompleted
1,007 participants
Started: Sep 27, 2016 · Completed: Mar 8, 2018
NCT02917200Lead Sponsor
Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy Volunteers
PHASE1Completed
150 participants
Started: May 11, 2016 · Completed: Dec 2, 2016
NCT02176005Lead Sponsor
Safety and Efficacy Study of DAV132 in Healthy Volunteers
PHASE1Completed
44 participants
Started: Mar 31, 2014 · Completed: Dec 31, 2014
View all 6 trials →